Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuropsychological Assessment of Remediation for Cognitive Impairments in Schizophrenia

NCT04608032 is registered in ClinicalTrials.gov with Centre hospitalier de Ville-Evrard, France as lead sponsor.

NCT NCT04608032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04608032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuropsychological Assessment of Remediation for Cognitive Impairments in Schizophrenia
Lead sponsor
Centre hospitalier de Ville-Evrard, France
Phase
Not applicable
Overall status
Unknown status
Start date
September 8, 2020
Completion date
December 1, 2024
Enrollment
70 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenic disorders